
Danish company MC Therapeutics' psoriasis cream Wynzora has cleared another obstacle on the way to the EU markets.
MC2 and its partner, dermatology company Almirall, announce in a press release that Wynzora has successfully completed the decentralized procedure.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app